Rocket Pharmaceuticals (RCKT) Return on Assets [ROA] (2015 - 2026)
Rocket Pharmaceuticals' Return on Assets [ROA] was -6.03% in Q2 2026, up 52.84 percentage points from -58.87% a year earlier and up 63.30 percentage points from the prior quarter.
Powered by 
Analysis
Rocket Pharmaceuticals (RCKT) Return on Assets [ROA] (2015 - 2026) Analysis & Trends
For FY2025, Return on Assets [ROA] at Rocket Pharmaceuticals came in at -53.70%, down 4.92 percentage points from FY2024.
- Return on Assets [ROA] has now declined for six consecutive years, with a five-year change of -24.81 percentage points (FY2020 to FY2025).
- In earlier years, Return on Assets [ROA] was -48.78% in FY2024 (-2.94 pp), -45.83% in FY2023 (-3.44 pp), -42.39% in FY2022 (-11.66 pp) and -30.73% in FY2021 (-1.84 pp).
- The Q2 2026 figure marks the highest quarterly Return on Assets [ROA] since Q3 2017.
- Compared with a year earlier, Return on Assets [ROA] was higher in two of the last eight quarters, with an average year-over-year change of -0.64 percentage points.
- The best year-over-year quarter for Return on Assets [ROA] over five years was Q2 2026 (a gain of 52.84 percentage points); the worst was Q1 2026 (a drop of 16.16 percentage points).
- Per Business Quant data, RCKT's Return on Assets [ROA] in the three quarters before Q2 2026 was -69.33% (Q1 2026), -65.34% (Q4 2025) and -62.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 10.47% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 28.37% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.14% |
| 10 | Rocket Pharmaceuticals | 280.42 Mn | 280.42 Mn | - | -6.03% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.03% |
| Mar 31, 2026 | -69.33% |
| Dec 31, 2025 | -65.34% |
| Sep 30, 2025 | -62.36% |
| Jun 30, 2025 | -58.87% |
| Mar 31, 2025 | -53.17% |
| Dec 31, 2024 | -57.92% |
| Sep 30, 2024 | -63.85% |
| Jun 30, 2024 | -55.78% |
| Mar 31, 2024 | -48.85% |
| Dec 31, 2023 | -43.99% |
| Sep 30, 2023 | -49.34% |
| Jun 30, 2023 | -52.23% |
| Mar 31, 2023 | -45.13% |
| Dec 31, 2022 | -45.88% |
| Sep 30, 2022 | -46.63% |
| Jun 30, 2022 | -42.54% |
| Mar 31, 2022 | -35.42% |
| Dec 31, 2021 | -32.54% |
| Sep 30, 2021 | -34.51% |
API Access
Rocket Pharmaceuticals Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RCKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RCKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RCKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();